IB
Immix Biopharma Inc
🇺🇸XNAS.IMMXUnited StatesHealthcare
$12.20USDup +0.05 (+0.41%)OpenDelayed6:07 PM
Price$12.20+0.05 (+0.41%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US45258H1068
- CUSIP
- 45258H106
Company
- Employees
- 21
- Headquarters
- Los Angeles, United States
- Website
- https://www.immixbio.com
- CEO
- Dr. Ilya Rachman M.B.A., M.D., Ph.D.
Market
- Shares outstanding
- 71.5M
- Market cap
- $872.78M
Key dates
- Next earnings
- Nov 6, 2026
Highlights
- Market cap
- $863.48M
- EPS LTM
- -$0.56calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -21.86calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$39.92M-72.6%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$39.09M-189.95%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.